Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning.
Cremonesi M, Ferrari ME, Bodei L, Chiesa C, Sarnelli A, Garibaldi C, Pacilio M, Strigari L, Summers PE, Orecchia R, Grana CM, Botta F. Cremonesi M, et al. Among authors: ferrari me. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2426-2441. doi: 10.1007/s00259-018-4044-x. Epub 2018 May 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29785514 Free PMC article. Review.
3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy.
Ferrari ME, Cremonesi M, Di Dia A, Botta F, De Cicco C, Sarnelli A, Pedicini P, Calabrese M, Orecchia R, Pedroli G, Paganelli G. Ferrari ME, et al. Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1702-11. doi: 10.1007/s00259-012-2197-6. Epub 2012 Aug 14. Eur J Nucl Med Mol Imaging. 2012. PMID: 22890802
Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations.
Sarnelli A, Guerriero F, Botta F, Ferrari M, Strigari L, Bodei L, D'Errico V, Grassi E, Fioroni F, Paganelli G, Orecchia R, Cremonesi M. Sarnelli A, et al. Q J Nucl Med Mol Imaging. 2017 Jun;61(2):216-231. doi: 10.23736/S1824-4785.16.02744-8. Epub 2015 Nov 17. Q J Nucl Med Mol Imaging. 2017. PMID: 26576734
Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II study.
Bodei L, Cremonesi M, Grana CM, Fazio N, Iodice S, Baio SM, Bartolomei M, Lombardo D, Ferrari ME, Sansovini M, Chinol M, Paganelli G. Bodei L, et al. Among authors: ferrari me. Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2125-35. doi: 10.1007/s00259-011-1902-1. Epub 2011 Sep 3. Eur J Nucl Med Mol Imaging. 2011. PMID: 21892623 Clinical Trial.
Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.
Cremonesi M, Gilardi L, Ferrari ME, Piperno G, Travaini LL, Timmerman R, Botta F, Baroni G, Grana CM, Ronchi S, Ciardo D, Jereczek-Fossa BA, Garibaldi C, Orecchia R. Cremonesi M, et al. Among authors: ferrari me. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1915-1927. doi: 10.1007/s00259-017-3762-9. Epub 2017 Jul 5. Eur J Nucl Med Mol Imaging. 2017. PMID: 28681192 Review.
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.
Paganelli G, De Cicco C, Ferrari ME, Carbone G, Pagani G, Leonardi MC, Cremonesi M, Ferrari A, Pacifici M, Di Dia A, De Santis R, Galimberti V, Luini A, Orecchia R, Zurrida S, Veronesi U. Paganelli G, et al. Among authors: ferrari me, ferrari a. Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):203-11. doi: 10.1007/s00259-009-1260-4. Epub 2009 Sep 4. Eur J Nucl Med Mol Imaging. 2010. PMID: 19760414 Clinical Trial.
154 results